Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients.

Tomohiro OnishiYusuke NakanoKen-Ichi HiranoYasuyuki NagasawaToru NiwaAtomu TajimaHideki Ishii Hiroshi TakahashiShinichiro SakuraiHirohiko AndoHiroaki TakashimaTetsuya Amano

Published in: Heart (British Cardiac Society) (2020)

TGCV is not uncommon in HD patients and is associated with an increased risk of cardiovascular events including cardiovascular death. Thus, TGCV might be a potential therapeutic target.

Keyphrases

end stage renal disease
cardiovascular events
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
cardiovascular disease
type diabetes
patient reported outcomes
risk assessment